← Evidence map

ReviewBMJ paediatrics open2023

Regulatory considerations for paediatric drug evaluation in China.

Ying Geng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37130653